Hwang, I.; Lee, S.-R.; Kim, H.J.; Kim, Y.; Lee, S.W.
Safety, Pharmacokinetics, and Food Effect of the RORα Agonist TB-840, a Novel Candidate for Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Randomized First-in-Human Study in Healthy Volunteers. Life 2025, 15, 1410.
https://doi.org/10.3390/life15091410
AMA Style
Hwang I, Lee S-R, Kim HJ, Kim Y, Lee SW.
Safety, Pharmacokinetics, and Food Effect of the RORα Agonist TB-840, a Novel Candidate for Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Randomized First-in-Human Study in Healthy Volunteers. Life. 2025; 15(9):1410.
https://doi.org/10.3390/life15091410
Chicago/Turabian Style
Hwang, Inyoung, Shi-Ra Lee, Heung Jae Kim, Yun Kim, and Sang Won Lee.
2025. "Safety, Pharmacokinetics, and Food Effect of the RORα Agonist TB-840, a Novel Candidate for Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Randomized First-in-Human Study in Healthy Volunteers" Life 15, no. 9: 1410.
https://doi.org/10.3390/life15091410
APA Style
Hwang, I., Lee, S.-R., Kim, H. J., Kim, Y., & Lee, S. W.
(2025). Safety, Pharmacokinetics, and Food Effect of the RORα Agonist TB-840, a Novel Candidate for Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Randomized First-in-Human Study in Healthy Volunteers. Life, 15(9), 1410.
https://doi.org/10.3390/life15091410
